The UK Health Security Agency (UKHSA) has updated who will be offered the COVID-19 booster this autumn. The programme is now more limited than in 2024, so it’s important to know if you qualify.
Who will be offered the booster?
You can get a free COVID-19 booster this autumn if you are:
-
Aged 75 or over
-
Living in a care home for older adults
-
Aged 6 months or older and immunosuppressed
This is a change from 2024, when everyone aged 65+ and many other clinical risk groups were included.
What “immunosuppressed” means
Many people with aspergillosis fall into this category. You may be considered immunosuppressed if you are:
-
Taking systemic steroids for more than a month
-
Receiving biologic therapy or other immunomodulatory medication
-
Living with a condition that affects your immune system
-
Having had chemotherapy, radiotherapy, or a transplant
If you’re unsure whether this applies to you, check with your GP or hospital specialist.
Timing of the booster
-
Boosters are usually offered at least 6 months after your last dose, including the spring booster.
-
Even if you’ve never had a COVID-19 vaccine before, you can still get one this autumn if you are in one of the eligible groups.
Why this matters for aspergillosis patients
People with aspergillosis often have weaker lungs and higher risks from infections. If your immune system is also suppressed by medication or illness, COVID-19 can be more severe. The booster offers added protection during the winter months.
💙 Key advice:
-
If you are immunosuppressed or over 75, you should be offered the vaccine.
-
If you think you qualify but haven’t received an invitation, speak to your GP or specialist.
-
Don’t delay — protecting yourself against COVID-19 is especially important when living with aspergillosis.
📌 Full details from UKHSA: Who’s eligible for the 2025 COVID-19 vaccine or autumn booster
Share this post
Latest News posts
HEPA filters & heat to reduce exposure to allergens
March 18, 2025
How the UK evaluates new drugs for use in the NHS
March 4, 2025
ABPA & CPA: Patient priorities
February 25, 2025
I Have ABPA and feel worse if I sleep with windows open
February 25, 2025
How the NHS funds medications
February 25, 2025
Thinking about joining a clinical trial? What are your concerns?
December 12, 2024
Biologics & ABPA – what are they and what can they do?
October 19, 2024
UK National RSV vaccination program launched
July 26, 2024
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
